Autism Speaks Through Gene Expression
Topic: Autism Information
Author: American Institute of Physics
Published: 2013/02/01 - Updated: 2024/03/06
Publication Type: Announcement / Notification - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Findings add a new candidate for genetic screening of at-risk patients that may lead to better diagnosis or treatment of autism. Autism is the most inheritable of neuro-developmental disorders but identifying the underlying genes is difficult since no single gene contributes more than a tiny fraction of autism cases. Although the research is still at an early stage, drugs that target the cellular pathways regulated by NHE9 could compensate for its loss of function and lead to potential therapy in the future.
Introduction
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment.
Main Item
New work to examine which genes are responsible for autism disorders was presented at the 57th Annual Meeting of the Biophysical Society (BPS) in Philadelphia, Pa.
"Autism is the most inheritable of neuro-developmental disorders," explains Rajini Rao of Johns Hopkins University in Baltimore, Md., "but identifying the underlying genes is difficult since no single gene contributes more than a tiny fraction of autism cases." Rather, she continues, "mutations in many different genes variably affect a few common pathways."
A team of scientists at Johns Hopkins and Tel Aviv University in Israel looked at genetic variations in DNA sequence in the ion transporter NHE9 and found that autism-associated variants in NHE9 result in a profound loss of transporter function.
"Altering levels of this transporter at the synapse may modulate critical proteins on the cell surface that bring in nutrients or neurotransmitters such as glutamate," says Rao. "Elevated glutamate levels are known to trigger seizures, possibly explaining why autistic patients with mutations in these ion transporters also have seizures."
A unique aspect of the team's approach was that they exploited decades of basic research done in bacteria and yeast to study a complex human neurological disorder.
First, the group at Tel Aviv University, led by Nir Ben-Tal, built structural models of NHE9 using a bacterial relative as a template, allowing the Rao laboratory at Johns Hopkins to use the simple baker's yeast for screening the mutations. In the future, as genomic information becomes readily available for everyone, such easy, inexpensive, and rapid screening methods will be essential to evaluate rare genetic variants in autism and other disorders.
Rao and her team are optimistic about the potential benefits of their latest findings.
"Although the research is still at an early stage, drugs that target the cellular pathways regulated by NHE9 could compensate for its loss of function and lead to potential therapy in the future," Rao says. "These findings add a new candidate for genetic screening of at-risk patients that may lead to better diagnosis or treatment of autism."
Presentation #118-Plat, "Functional evaluation of autism associated mutations in SLC9A9 (NHE9)," took place at 9:15 a.m. on Sunday, Feb. 3, 2013, in the Pennsylvania Convention Center, Room 113C.
Attribution/Source(s):
This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by American Institute of Physics, and published on 2013/02/01 (Edit Update: 2024/03/06), the content may have been edited for style, clarity, or brevity. For further details or clarifications, American Institute of Physics can be contacted at aip.org. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Explore Related Topics
1 - Autistic Adults Share Struggles with Misdiagnosis of Borderline Personality Disorder - Phenomenological study on the lived experiences of autistic adults who were previously diagnosed with Borderline Personality Disorder (BPD).
2 - Deleting a Single Key Gene Causes Autistic Traits - Researchers found that knocking out the Astrotactin 2 gene leads to several hallmark behaviors of autism.
3 - Research Papers on Autism Spectrum Disorders: Causes and Treatments - Comprehensive list of studies and research articles on the causes and treatments of autism spectrum disorders.
4 - Umbilical Cord Blood Fatty Acids Linked to Autism Spectrum Disorder - Researchers unveil the link between cord blood fatty acid metabolites and autism spectrum disorder (ASD) symptoms in children.
5 - Cancer Medication May Improve Cognitive Function in Some Autism Cases - New research highlights a therapeutic target that could make thinking easier for patients with Rett syndrome and other neurological disorders.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): American Institute of Physics. (2013, February 1 - Last revised: 2024, March 6). Autism Speaks Through Gene Expression. Disabled World. Retrieved October 9, 2024 from www.disabled-world.com/health/neurology/autism/gene-expression.php
Permalink: <a href="https://www.disabled-world.com/health/neurology/autism/gene-expression.php">Autism Speaks Through Gene Expression</a>: Findings add a new candidate for genetic screening of at-risk patients that may lead to better diagnosis or treatment of autism.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.